Latest Islets of Langerhans Stories
FRIENDLY bacteria in the gut may protect against insulin- dependent diabetes, a study suggests. In tests on mice, the bugs appeared to stop the rogue immune response that triggers the disease.
In tests on mice, the bugs appeared to stop the rogue immune response that triggers the disease.Type 1 diabetes is caused by an autoimmune response which destroys insulin-producing islet cells in the pancreas.About 300,000 people in the UK suffer from the disease.
Research and Markets (http://www.researchandmarkets.com/research/d99eac/competitor_analysi) has announced the addition of the "Competitor Analysis: Emerging Diabetes Drugs" report to their offering.
Launching a counter-attack on the immune response that causes insulin-dependent diabetes may provide a revolutionary new way of treating the disease, research has shown.
MicroIslet Inc. (OTCBB: MIIS, http://www.microislet.com), a biotechnology company engaged in the development and commercialization of cell therapies for diabetes, has appointed Brian D. Conn to the positions of Vice President Corporate Finance and Chief Financial Officer. Mr.
Living Cell Technologies Limited (ASX: LCT) (PINKSHEETS: LVCLY) today announced that Professor Bob Elliott, Medical Director of LCT, will host a seminar on Friday, August 8, 2008, in Auckland, New Zealand for world leading medical scientists and specialists to discuss current developments with porcine islet transplant technologies.
Tissera, Inc. (OTCBB:TSSR) reports that on July 8, 2008, it has entered into a bridge loan agreement with an accredited investor, who was a participant in the Company's December 2006 fund raising.
MicroIslet Inc. (OTCBB: MIIS, http://www.microislet.com), a biotechnology company engaged in the development and commercialization of cell therapies for diabetes, is pleased to report recent safety and efficacy data.
Osiris Therapeutics, Inc.
- The parings of haberdine; also, any kind of fragments.